Product Information
TAXUS™ Liberté™ stent – The First Second generation DES designed for Drug Delivery Confidence to deliver to complex lesions
- TAXUS™ Liberté™ stent is designed to offer enhanced Lesion access in challenging anatomiesImproved deliverability and conformability² with thin struts (0.0038"), low tip profile (0.017") and low crossing profile³ (0.047").
- Excellent side branch access4 (4.2 mm side branch expanded diameter – for a 3.0 mm stent)
Confidence to deliver Paclitaxel uniformly²
- The TAXUS™ Liberté™ stent system is designed to provide
- uniform drug delivery
- Veriflex™ Architecture for an excellent vessel coverage and support
- small open cell area and 3 designs (small vessel, Workhorse and large vessel) to adapt the level of support to the diameter of the artery.
- Low recoil² for a better apposition and drug distribution.
Confidence in the comprehensive TAXUS™ clinical programme
The level of evidence You need to treat your patients with Confidence.
Device Illustration
Additional Information
1. Based on internal bench tests of the features of the Liberté™ Stent compared to Express²™ Stent and Market research results. Data on file.
2. Internal bench testing (n=3). Data on file.
3. 3.0 mm stent
4. Theoretical test method for cell expansion. Calculated number. Internal tests.
5. Based on internal bench tests of the features of the Liberté™ Stent compared to Express²™ Stent.
TAXUS™ Clinical trial programme.
PEBAX® is a registered trademark of Arkema
